Denali Therapeutics Inc.
USD25.89
+0.32 (+1.25%)
CEO
Ryan J. Watts
IPO Date
2017-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$25.54
Prev. Close
$25.57
Day Low
$25.54
Day High
$26.11
52W Low
$12.58
52W High
$26.19
Market Cap
$4.11B
Volume
2.13M
| 19,226 |
| $19.66 |
| 5 Jun 2026 | Klein Peter S | director | A-Award | Acquired | 6,408 | $0.00 |
| 5 Jun 2026 | Klein Peter S | director | A-Award | Acquired | 19,226 | $19.66 |
| 5 Jun 2026 | Krognes Steve E. | director | A-Award | Acquired | 6,408 | $0.00 |
| 5 Jun 2026 | Krognes Steve E. | director | A-Award | Acquired | 19,226 | $19.66 |
| 5 Jun 2026 | Schenkein David P | director | A-Award | Acquired | 6,408 | $0.00 |
| 5 Jun 2026 | Schenkein David P | director | A-Award | Acquired | 19,226 | $19.66 |
| 5 Jun 2026 | Thornberry Nancy | director | A-Award | Acquired | 6,408 | $0.00 |
| 5 Jun 2026 | Thornberry Nancy | director | A-Award | Acquired | 19,226 | $19.66 |